Quick Answer
HARVARD BIOSCIENCE INC reported Operating Income of -$48.58 million for fiscal year 2025.
HARVARD BIOSCIENCE INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$48.58M | -682.2% |
| 2024 | -$6.21M | -427.9% |
| 2023 | $1.89M | +127.3% |
| 2022 | -$6.93M | -435.6% |
| 2021 | $2.07M | +834.8% |
| 2020 | $221.0K | -41.4% |
| 2019 | $377.0K | -61.7% |
| 2018 | $984.0K | +255.0% |
| 2017 | -$635.0K | +78.8% |
| 2016 | -$3.00M | -75.0% |
| 2015 | -$1.71M | -125.9% |
| 2014 | $6.62M | +330.6% |
| 2013 | $1.54M | -80.4% |
| 2012 | $7.83M | -6.8% |
| 2011 | $8.40M | -17.7% |
| 2010 | $10.22M | +26.9% |
| 2009 | $8.05M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $197.0K | +110.5% | +124.1% |
| June 30, 2025 | -$819.0K | +60.4% | +98.4% |
| March 31, 2025 | -$49.67M | -2079.4% | -2550.4% |
| September 30, 2024 | -$1.87M | -100.9% | +9.4% |
| June 30, 2024 | -$2.07M | -359.9% | +9.2% |
| March 31, 2024 | -$2.28M | -230.3% | -144.3% |
| September 30, 2023 | -$933.0K | +75.2% | -217.2% |
| June 30, 2023 | $796.0K | -80.1% | -54.5% |
- HARVARD BIOSCIENCE INC showed a decrease of -682.2% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, HARVARD BIOSCIENCE INC’s operating income has declined by 703.1% (from $8.05 million to -$48.58 million).
- The most recent figure is from HARVARD BIOSCIENCE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: